# Generation and fluorescent formatting of aptamers targeting antiretroviral drugs (ARVs) for the detection of unreported ARV use on behalf of the CDC’s National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention Division of HIV Prevention.

Canonical: https://abierto.us/opportunities/cdc7d301nchhstp0001

- Solicitation number: CDC-7D301-NCHHSTP-0001
- Notice type: Combined synopsis and solicitation
- Status: Closed. Deadline was July 31, 2026 at 5:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Centers for Disease Control and Prevention
- Contracting office: CDC Office of Acquisition Services (75D301)
- NAICS: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Product or service code: AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Place of performance: Atlanta, Georgia
- First posted: July 29, 2026
- Last posted: July 29, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/ca72dd783c9a49a9b01880f107cfe23b/view

## Description

This is a combined synopsis/solicitation for a sole-source requirement. The Centers for Disease Control and Prevention (CDC) Office of Acquisition Services intends to award a sole source contract to Texas A&M University for services to provide generation and fluorescent formatting of aptamers targeting antiretroviral drugs (ARVs) for the detection of unreported ARV use on behalf of the CDC’s National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention Division of HIV Prevention.

Antiretroviral drugs (ARVs) are the foundation of HIV treatment and prevention. Detection of unreported ARV use is essential for surveillance, behavioral research, and blood safety monitoring. While liquid chromatography with tandem mass spectrometry (LC-MS-MS) remains the gold standard for ARV detection, it is costly, labor-intensive, and impractical for high-throughput or resource-limited settings.

These constraints limit its scalability for high-throughput surveillance and preclude its use in many public health or resource-limited laboratory settings. The Division of HIV Prevention Laboratory Branch (DHP LB) at the CDC is developing a high-throughput assay that leverages aptamer-based technologies and plate-based detection to enable efficient qualitative screening of ARVs that are priorities for surveillance and blood safety monitoring. The anticipated period of performance for a two-year multi-year contract from 8/03/2026 through 8/13/2028. The NAICS Code is:

541715 - Research and Development Laboratories or Services (except Biotechnology and Nanotechnology Research and Development) The PSC is:

AJ12 – General Science and Technology R&D Services As indicated above, this contract action is for services for which the Government intends to solicit and negotiate with only one source under the authority of Revolutionary FAR Overhaul 12.102(a), Restricting competition. No solicitation will be published for this requirement. This notice is issued solely to determine whether there are any responsible sources capable of meeting the Government’s requirements.

Interested parties may identify their interest and submit documentation of their capability to respond to this requirement. This notice of intent is not a request for competitive quotations/proposals; however, all responses received within the issuance period of this notice will be considered by the Government. A determination by the Government not to competitively solicit for the proposed contract action based upon responses to this notice is solely within the discretion of the Government.

Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Responses should be emailed to the Contracting Officer, Serina Allingham, xog9@cdc.gov, by 5:00p.m. on July 31, 2026.

## Publications

- July 29, 2026: Combined synopsis and solicitation, due July 31, 2026 at 5:00 PM EDT. Notice ca72dd783c9a49a9b01880f107cfe23b. https://sam.gov/workspace/contract/opp/ca72dd783c9a49a9b01880f107cfe23b/view

## Points of contact

- Serina Allingham, xog9@cdc.gov, 17704484602

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/cdc7d301nchhstp0001.